Evidence map›Paper›PMID 37047233›Full record

ArticleInternational journal of molecular sciences2023

Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins.

Lina Rozano, Yvonne M Mukuka, James K Hane, Ricardo L Mancera

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lina RozanoCurtin Medical School, Curtin Health Innovation Research Institute, GPO Box U1987, Perth, WA 6845, Australia.ORCID 0000-0002-6182-2089
Yvonne M MukukaCurtin Medical School, Curtin Health Innovation Research Institute, GPO Box U1987, Perth, WA 6845, Australia.
James K HaneCurtin Institute for Computation, Curtin University, GPO Box U1987, Perth, WA 6845, Australia.ORCID 0000-0002-7651-0977
Ricardo L ManceraCurtin Medical School, Curtin Health Innovation Research Institute, GPO Box U1987, Perth, WA 6845, Australia.ORCID 0000-0002-9191-5622

Funding

Curtin International Postgraduate Research Scholarship. N/A
6 · The paper itself

Abstract

Pathogenic fungal diseases in crops are mediated by the release of effector proteins that facilitate infection. Characterising the structure of these fungal effectors is vital to understanding their virulence mechanisms and interactions with their hosts, which is crucial in the breeding of plant cultivars for disease resistance. Several effectors have been identified and validated experimentally; however, their lack of sequence conservation often impedes the identification and prediction of their structure using sequence similarity approaches. Structural similarity has, nonetheless, been observed within fungal effector protein families, creating interest in validating the use of computational methods to predict their tertiary structure from their sequence. We used Rosetta ab initio modelling to predict the structures of members of the ToxA-like and MAX effector families for which experimental structures are known to validate this method. An optimised approach was then used to predict the structures of phenotypically validated effectors lacking known structures. Rosetta was found to successfully predict the structure of fungal effectors in the ToxA-like and MAX families, as well as phenotypically validated but structurally unconfirmed effector sequences. Interestingly, potential new effector structural families were identified on the basis of comparisons with structural homologues and the identification of associated protein domains.

Indexed as

AscomycotaDisease ResistanceFungal ProteinsPlant BreedingPlant DiseasesVirulenceFungal Proteinsab initio modellingfungal effector proteinMaxClusterMAX effector familyRosettaTM-scoreToxA-like effector family

Identifiers

PMID37047233
PMCPMC10094246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.